Korean Government grant awarded from NRF

관리자 │ 2023-01-17



Selected a new drug development program including government grant (₩600M) from National Research Foundation of Korea. This program will enable AevisBio to further develop the TPD platform technologies. AevisBio will open the Chemical Research Center at Institut Pasteur Korea in Pangyo, Korea, through this program.  

Previous Post AevisBio entered into a collaborative research with KRISS
Next Post Patent license agreement with NIH